Rw. Snow et al., RELATION BETWEEN SEVERE MALARIA MORBIDITY IN CHILDREN AND LEVEL OF PLASMODIUM-FALCIPARUM TRANSMISSION IN AFRICA, Lancet, 349(9066), 1997, pp. 1650-1654
Background Malaria remains a major cause of mortality and morbidity in
Africa; Many approaches to malaria control involve reducing the chanc
es of infection but little is known of the relations between parasite
exposure and the development of effective clinical immunity so the lon
gterm effect of suck approaches to control on the pattern and frequenc
y of malaria cannot be predicted. Methods We have prospectively record
ed paediatric admissions with severe malaria over three to five years
from five discrete communities in The Gambia and Kenya, Demographic an
alysis of the communities exposed to disease risk allowed the estimati
on of age-specific rates for severe malaria. Within each community the
exposure to Plasmodium falciparum infection was determined through re
peated parasitological and serological surveys among children and infa
nts,We used acute respiratory-tract infections (ARI) as a comparison.
Findings 3556 malaria admissions were recorded for the five sites. Mar
ked differences were observed in age, clinical spectrum and rates of s
evere malaria between the five sites, Paradoxically, the risks of seve
re disease in childhood were lowest among populations with the highest
transmission intensities, and the highest disease risks were observed
among populations exposed to low-to-moderate intensities of transmiss
ion. For severe malaria, for example, admission rates (per 1000 per ye
ar) for children up to their 10th birthday were estimated as 3.9, 25.8
, 25.9, 16.7 and 18.0 in the five communities; the forces of infection
estimated for those communities (new infections per infant per month)
were 0.001, 0.034, 0.050, 0.093, and 0.176, respectively. Similar tre
nds were noted for cerebral malaria and for severe malaria anaemia but
not for ARI. Mean age of disease decreased with increasing transmissi
on intensity. Interpretation We propose that a critical determinant of
life-time disease risk is the ability to develop clinical immunity ea
rly in life during a period when other protective mechanisms may opera
te. In highly endemic areas measures which reduce parasite transmissio
n,and thus immunity, may lead to a change in both the clinical spectru
m of severe disease and the overall burden of severe malaria morbidity
.